Use of zidovudine in human immunodeficiency virus-induced hepatitis.
AUTOR(ES)
Wertheim, D L
RESUMO
Hepatitis is a common complication of human immunodeficiency virus (HIV) disease in children. Often a distinct pathogen cannot be identified. Therefore, by exclusion, one must consider HIV the direct pathogen. Zidovudine (AZT) has not been used as a treatment for HIV-positive children with presumed HIV-induced hepatitis because of the potential of this medication to exacerbate preexisting hepatitis. We have used AZT to treat an 8-month-old female with severe HIV-induced hepatitis and have achieved complete remission with this regimen. For some HIV-positive children with HIV-induced hepatitis, AZT may be the drug of choice to resolve hepatic inflammation caused by this virus.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=368264Documentos Relacionados
- Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation.
- Use of Fluoroquinolones in Patients with Chronic Hepatitis C Virus-Induced Liver Failure
- Mechanism of Human Immunodeficiency Virus-Induced Complement Expression in Astrocytes and Neurons
- Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome.
- Human cytomegalovirus. III. Virus-induced DNA polymerase.
